CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

Butalbital, Acetaminophen and Caffeine

butalbital, acetaminophen and caffeine· ingredient acetaminophenOther dermatologicals· ACETAMINOPHEN 300 mg/1; BUTALBITAL 50 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.33136
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per EA — the trend nobody else shows. 7 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other acetaminophen products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.

ProductNADAC / EAvs this
Acetaminophen Oral Solution$0.01218−$0.31920
Basic Care Daytime Cold and Flu$0.01348−$0.31790
24-7 Life BY 7-ELEVEN Nighttime Cold and Flu$0.01504−$0.31630
Acetaminophen Extra Strength$0.01901−$0.31240
ADWE Childrens Pain Fever$0.02109−$0.31030
basic care tussin cf severe$0.02410−$0.30730
Acetaminophen 325mg$0.02520−$0.30620
365 whole foods market acetaminophen$0.03423−$0.29710

Medicare Part D coverage · CY2026

On 64 plan formularies · typical tier 4
Prior auth 58% · Step therapy 0% · Quantity limit 92% of formularies

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.